CClinicalTrials.gg
CompletedNCT04759183Updated Sep 7, 2022

Virtual Reality Experiences for Anxiety and Pain Control

An interventional study of Survey Administration and Virtual Reality Game in Hematopoietic and Lymphoid Cell Neoplasm and Malignant Solid Neoplasm, sponsored by OHSU Knight Cancer Institute. Completed at 1 site in United States. Open to participants aged 18 Years to 89 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-09-07.

Sponsored by OHSU Knight Cancer Institute · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Randomized
Ages
18 Years to 89 Years
Sex
All
01

Study summary

This trial studies the impact of virtual reality experiences on anxiety before surgery and pain after surgery. The goal of this study is to examine how different virtual reality experiences may help reduce anxiety and improve pain control, which may help reduce the need for medications such as opioids.

Read the detailed description

PRIMARY OBJECTIVE:

I. To measure the impact of a gaming virtual reality (VR) experience compared to a mindfulness VR experience on preoperative anxiety and postoperative pain.

OUTLINE: Patients are randomized to 1 of 2 arms.

ARM I: Patients participate in a VR intervention (Angry Birds) over 15 minutes before standard of care surgery and then participate in a VR intervention (TRIPP) over 15 minutes after surgery.

ARM II: Patients participate in a VR intervention (TRIPP) over 15 minutes before standard of care surgery and then participate in a VR intervention (Angry Birds) over 15 minutes after surgery.

02

Conditions studied

  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm

Browse trials for

03

In context

Neoplasms

9,365 studies on the registry are indexed under Neoplasms; 2,489 are open to participants now.

This study's enrollment of 32 is below the median of 50 across 7,253 interventional studies indexed under Neoplasms.

Browse Neoplasms studies →

Lead sponsor

OHSU Knight Cancer Institute is the lead sponsor of 242 studies on the registry; 45 are open to participants now.

Of its 27 completed or terminated interventional studies of FDA-regulated products, 15 (56%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 89 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Adults (18 years or older and younger than 89)
  • Able to consent
  • English-speaking

Exclusion criteria

Exclusion Criteria:

  • Non-English speaking patients because the VR content is only available in English
  • Have symptoms concerning for an active respiratory infection or are on contact or isolation precautions
  • Any active eye discharge
  • A history of seizure, epilepsy, or hypersensitivity to flashing light
  • Have a history of motion sickness or vertigo
  • Have active nausea or vomiting
  • Psychiatric conditions that may interfere with the ability to successfully participate in the study
  • Have cardiac pacemakers
  • Require hearing aids at all times that cannot be removed
  • Have defibrillators
  • Have wound dressings on the head or neck that prevent comfortable use of the VR headset
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
32 participants (actual)

Study arms

  • Experimental
    Arm I (Angry Birds, TRIPP)

    Patients participate in a VR intervention (Angry Birds) over 15 minutes before standard of care surgery and then participate in a VR intervention (TRIPP) over 15 minutes after surgery.

    Other: Survey Administration · Procedure: Virtual Reality Game · Procedure: Virtual Reality Meditation

  • Experimental
    Arm II (TRIPP, Angry Birds)

    Patients participate in a VR intervention (TRIPP) over 15 minutes before standard of care surgery and then participate in a VR intervention (Angry Birds) over 15 minutes after surgery.

    Other: Survey Administration · Procedure: Virtual Reality Game · Procedure: Virtual Reality Meditation

Interventions

  • OtherSurvey Administration

    Ancillary studies

  • ProcedureVirtual Reality Game

    Participate in VR Game "Angry Birds"

    Also known as: VR Game

  • ProcedureVirtual Reality Meditation

    Participate in VR Meditation "TRIPP"

    Also known as: VR Meditation

06

What researchers measure

Primary outcomes

  1. Change in preoperative anxiety scores

    Assessed by visual analogue scale (VAS) from 0-100mm.

    Time frame: Baseline up to pre surgery (estimated 1 day)

  2. Change in postoperative pain scores

    Assessed by VAS scale from 0-100mm.

    Time frame: Baseline after surgery up to study completion (estimated 1 day)

Secondary outcomes

  1. Change in blood pressure

    mmHg

    Time frame: immediately before intervention, and then immediately after intervention (estimated 1 day)

  2. Patient enjoyment of each VR experience

    Likert scale (1-5). 1 represents the lowest score, and 5 represents the highest.

    Time frame: Up to study completion (estimated 1 day)

  3. Change in heart rate

    beats per minute (bpm)

    Time frame: immediately before intervention, and then immediately after intervention (estimated 1 day)

  4. Patient desire to use VR more in their healthcare

    Likert scale (1-5). 1 represents the lowest score, and 5 represents the highest.

    Time frame: Up to study completion (estimated 1 day)

07

Study locations

1 site
  • OHSU Knight Cancer Institute
    Portland, Oregon 97239, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 7, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04759183
Lead sponsor
OHSU Knight Cancer Institute
Collaborators
Oregon Health and Science University
Responsible party
Ryan Li, MD (Principal Investigator, OHSU Knight Cancer Institute) — Principal investigator
First posted
Feb 18, 2021
Start date
Mar 5, 2021
Primary completion
Apr 11, 2022
Completion
Aug 25, 2022
Last update
Sep 7, 2022

Study contacts

Ryan J Li
principal investigator · OHSU Knight Cancer Institute

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion